Eli Lilly and Co
XHAM:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
XHAM:LLY
|
US |
|
Rush Enterprises Inc
NASDAQ:RUSHA
|
US |
|
H
|
Heidelberg Pharma AG
XHAM:HPHA
|
DE |
|
M
|
Manhattan Gold Corporation Ltd
ASX:MHC
|
AU |
|
Keramika Indonesia Assosiasi Tbk PT
IDX:KIAS
|
ID |
|
T
|
Taiwan Secom Co Ltd
TWSE:9917
|
TW |
|
Toast Inc
F:71Y
|
US |
|
C
|
Caseys General Stores Inc
SWB:CS2
|
US |
|
M&G PLC
LSE:MNG
|
UK |
|
R
|
Recordati Industria Chimica e Farmaceutica SpA
OTC:RCDTF
|
IT |
|
E
|
European Lithium Ltd
F:PF8
|
AU |
|
F
|
Frontline Plc
F:HF6
|
CY |
|
Kering SA
PAR:KER
|
FR |
|
El Pollo Loco Holdings Inc
NASDAQ:LOCO
|
US |
|
Nissan Chemical Corp
OTC:NNCHF
|
JP |
|
B
|
Breville Group Ltd
OTC:BVILY
|
AU |
|
C
|
Comture Corp
TSE:3844
|
JP |
|
TPG Telecom Ltd
ASX:TPG
|
AU |
|
U
|
Unilever PLC
VSE:ULVR
|
UK |
|
IPD Group Ltd
F:IS6
|
AU |
|
Toray Industries Inc
TSE:3402
|
JP |
|
Pieris Pharmaceuticals Inc
F:PI6
|
US |
|
A
|
ASR Nederland NV
SWB:A16
|
NL |
|
C
|
Carvana Co
F:CV0
|
US |
Bankruptcy Probability
Eli Lilly and Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Eli Lilly and Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
622.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
355B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
338.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
160.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Eli Lilly and Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Eli Lilly and Co has total debt of 53.1B USD. This includes both short-term (5.3B USD) and long-term (47.9B USD) debt.
You can find a full breakdown on its Balance Sheet.